Effect of intravenous dexamethasone palmitate compared withdexamethasone on the block duration in pediatric patients undergoingupper extremity fracture surgery:Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0011764

Enrollment

Registered

2026-03-23

Start date

2026-04-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : When the patient arrives in the operating room, standard monitoring is performed, and general anesthesia is administered. Perform a brachial plexus block using 0.2%ropivacaine to 1 mL/kg (2 mg/

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 5 to 15 years old

Exclusion criteria

Exclusion criteria: 1) Patients with adverse reactions to local anesthetics 2) Patients with contraindications to nerve blocks such as blood coagulation disorders or infections 3) Patient does not agree to participate in the study 4) Patients who are contraindicated for dexamethasone or dexamethasone palmitate (diabetic patients, patients with infectious diseases or septic) 5) Patients who have been treated with corticosteroids from 7 days before surgery to the day of surgery 6) Chronic opioid use (Chronic opioid use)

Design outcomes

Primary

Measure	Time frame
Time taken for sensory/motor function to return after surgery	—

Secondary

Measure	Time frame
Pain scores (NRS) at 0, 6, and 24 hours post-surgery	—

Countries

Korea, Republic of

Contacts

Public ContactYoung Jin Roh

Asan Medical Center

clever8808@naver.com+82-2-3010-3858

Outcome results